Back-Madruga Carla, Boone Kyle Brauer, Briere John, Cummings Jeffrey, McPherson Susan, Fairbanks Lynn, Thompson Elizabeth
University of Southern California, Keck School of Medicine, Los Angeles, CA 90033, USA.
Clin Neuropsychol. 2002 Aug;16(3):331-40. doi: 10.1076/clin.16.3.331.13846.
A frontal, or executive, variant of Alzheimer's disease (EAD) has been described in the literature in which frontal dysfunction accompanies temporal and parietal changes in the early stages of the illness. However, no study has empirically investigated associated aspects, such as neuropsychiatric symptoms, instrumental activities of daily living, or caregiver burden in this EAD subgroup. We compared the performance of two subgroups of mild Alzheimer's disease patients (e.g., EAD and typical Alzheimer's disease; TAD) on neuropsychological and associated measures. Results revealed that the EAD group, selected based on poor executive scores, did not significantly differ from the TAD group on nonexecutive neuropsychological tests of intelligence, language, verbal and nonverbal memory, or visual-spatial abilities. However, the EAD group evidenced more severe neuropsychiatric symptoms, impaired activities of daily living, and greater caregiver distress than the TAD group. Thus, the EAD subgroup is characterized by executive dysfunction, neuropsychiatric symptoms, and functional disability in excess of that seen in TAD. Whether our EAD subgroup represents an actual frontal variant of Alzheimer's disease awaits replication in a larger sample including neuroimaging and pathological confirmation, as well as longitudinal assessment of cognition and neuropsychiatric symptoms.
文献中描述了阿尔茨海默病的一种额叶或执行功能变异型(EAD),在疾病早期,额叶功能障碍伴随着颞叶和顶叶的变化。然而,尚无研究实证调查该EAD亚组的相关方面,如神经精神症状、日常生活工具性活动或照料者负担。我们比较了轻度阿尔茨海默病患者的两个亚组(即EAD和典型阿尔茨海默病;TAD)在神经心理学及相关测量方面的表现。结果显示,基于执行功能得分低而选出的EAD组,在智力、语言、言语和非言语记忆或视觉空间能力的非执行神经心理学测试中,与TAD组无显著差异。然而,EAD组比TAD组表现出更严重的神经精神症状、日常生活活动受损及照料者更大的痛苦。因此,EAD亚组的特征是执行功能障碍、神经精神症状和功能残疾,其程度超过TAD组。我们的EAD亚组是否代表阿尔茨海默病的一种实际额叶变异型,有待在包括神经影像学和病理学证实以及认知和神经精神症状纵向评估的更大样本中进行重复验证。